Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123810782 | 12381078 | 2 | F | 20160421 | 20160901 | 20160518 | 20160913 | EXP | JP-ELI_LILLY_AND_COMPANY-JP201605005210 | ELI LILLY AND CO | 79.00 | YR | M | Y | 55.00000 | KG | 20160912 | CN | DE | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123810782 | 12381078 | 1 | PS | ERBITUX | CETUXIMAB | 1 | Intravenous (not otherwise specified) | 415 MG, OTHER | Y | U | 125084 | 415 | MG | INJECTION | |||||
| 123810782 | 12381078 | 2 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | 165 MG, OTHER | Y | 0 | 165 | MG | |||||||
| 123810782 | 12381078 | 3 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | 1000 MG, OTHER | Y | 0 | 1000 | MG | |||||||
| 123810782 | 12381078 | 4 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | 140 MG, OTHER | Y | 0 | 140 | MG | |||||||
| 123810782 | 12381078 | 5 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | 85 MG, OTHER | Y | 0 | 85 | MG | |||||||
| 123810782 | 12381078 | 6 | C | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | Unknown | 165 MG, UNKNOWN | Y | 0 | 165 | MG | |||||||
| 123810782 | 12381078 | 7 | C | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | Unknown | 100 MG, OTHER | Y | 0 | 100 | MG | |||||||
| 123810782 | 12381078 | 8 | C | NASEA | RAMOSETRON HYDROCHLORIDE | 1 | Oral | UNK UNK, UNKNOWN | 0 | ||||||||||
| 123810782 | 12381078 | 9 | C | DECADRON | DEXAMETHASONE | 1 | Unknown | UNK UNK, UNKNOWN | 0 | ||||||||||
| 123810782 | 12381078 | 10 | C | EMEND | APREPITANT | 1 | Oral | UNK UNK, UNKNOWN | 0 | ||||||||||
| 123810782 | 12381078 | 11 | C | RESTAMINE | 2 | Unknown | UNK UNK, UNKNOWN | 0 | |||||||||||
| 123810782 | 12381078 | 12 | C | BETAMETHASONE. | BETAMETHASONE | 1 | Oral | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123810782 | 12381078 | 1 | Colorectal cancer |
| 123810782 | 12381078 | 2 | Colorectal cancer |
| 123810782 | 12381078 | 4 | Colorectal cancer |
| 123810782 | 12381078 | 6 | Colorectal cancer |
| 123810782 | 12381078 | 8 | Prophylaxis |
| 123810782 | 12381078 | 9 | Prophylaxis |
| 123810782 | 12381078 | 10 | Prophylaxis |
| 123810782 | 12381078 | 11 | Prophylaxis |
| 123810782 | 12381078 | 12 | Metastases to central nervous system |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123810782 | 12381078 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123810782 | 12381078 | Decreased appetite | |
| 123810782 | 12381078 | Diarrhoea | |
| 123810782 | 12381078 | Interstitial lung disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123810782 | 12381078 | 1 | 20151225 | 20160420 | 0 | |
| 123810782 | 12381078 | 2 | 20151225 | 20160420 | 0 | |
| 123810782 | 12381078 | 3 | 20151225 | 20160420 | 0 | |
| 123810782 | 12381078 | 4 | 20151225 | 0 | ||
| 123810782 | 12381078 | 5 | 20151225 | 0 | ||
| 123810782 | 12381078 | 6 | 20151225 | 20160420 | 0 | |
| 123810782 | 12381078 | 7 | 20151225 | 20160420 | 0 | |
| 123810782 | 12381078 | 8 | 20151225 | 0 | ||
| 123810782 | 12381078 | 9 | 20151225 | 0 | ||
| 123810782 | 12381078 | 10 | 20151225 | 0 | ||
| 123810782 | 12381078 | 11 | 20151225 | 0 | ||
| 123810782 | 12381078 | 12 | 20151204 | 0 |